Roivant Sciences Ltd.
ROIV
41 insider filings · Latest: Jun 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Dec 23 9:04 PM | ERIC VENKER | Proposed Sale | 200,000 | $22.45 | $4.5M | — | View → |
| Dec 17, 2025 | Dec 17 10:09 PM | Sukhatme Mayukh | Proposed Sale | 26,831 | $23.09 | $619.5K | — | View → |
| Dec 15, 2025 | Dec 15 10:13 PM | Gline Matthew | Proposed Sale | 1,740,000 | $21.68 | $37.7M | — | View → |
| Dec 15, 2025 | Dec 15 9:36 PM | Gline Matthew | Proposed Sale | 1,740,000 | $21.68 | $37.7M | — | View → |
| Dec 9, 2025 | Dec 9 9:49 PM | Venker Eric | Proposed Sale | 200,000 | $20.85 | $4.2M | — | View → |
| Nov 7, 2025 | Nov 7 8:15 PM | Venker Eric | Proposed Sale | 200,000 | $20.22 | $4.0M | — | View → |
| Oct 17, 2025 | Oct 17 8:01 PM | Venker Eric | Proposed Sale | 118,418 | $17.06 | $2.0M | — | View → |
| Oct 16, 2025 | Oct 16 8:37 PM | Venker Eric | Proposed Sale | 318,282 | $17.05 | $5.4M | — | View → |
| Oct 15, 2025 | Oct 15 8:23 PM | Venker Eric | Proposed Sale | 414,683 | $16.93 | $7.0M | — | View → |
| Oct 13, 2025 | Oct 14 12:51 PM | Venker Eric | Proposed Sale | 20,727 | $16.25 | $336.9K | — | View → |
| Oct 9, 2025 | Oct 9 8:12 PM | Venker Eric | Proposed Sale | 104,940 | $16.30 | $1.7M | — | View → |
| Oct 8, 2025 | Oct 8 8:15 PM | Venker Eric | Proposed Sale | 138,602 | $16.20 | $2.2M | — | View → |
| Oct 7, 2025 | Oct 7 8:34 PM | Venker Eric | Proposed Sale | 355,161 | $16.15 | $5.7M | — | View → |
| Oct 6, 2025 | Oct 6 8:46 PM | Venker Eric | Proposed Sale | 171,396 | $16.34 | $2.8M | — | View → |
| Sep 23, 2025 | Sep 23 1:45 PM | Venker Eric | Proposed Sale | 611,079 | $14.94 | $9.1M | — | View → |
| Sep 22, 2025 | Sep 22 8:20 PM | ERIC VENKER | Proposed Sale | 316,182 | $14.99 | $4.7M | — | View → |
| Sep 22, 2025 | Sep 22 8:07 PM | Venker Eric | Proposed Sale | 100,000 | $15.01 | $1.5M | — | View → |
| Sep 19, 2025 | Sep 19 8:32 PM | ERIC VENKER | Proposed Sale | 683,818 | $14.95 | $10.2M | — | View → |
| Aug 20, 2025 | Aug 20 8:30 PM | Venker Eric | Proposed Sale | 100,000 | $11.72 | $1.2M | — | View → |
| Jul 21, 2025 | Jul 21 8:34 PM | Venker Eric | Proposed Sale | 100,000 | $11.52 | $1.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
| Jun 25, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,724,363(D) | View → |
| Jun 24, 2026 | Jun 26 10:13 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,244,834(D) | View → |
| May 22, 2026 | May 22 10:25 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,444,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:27 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,644,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Richard PulikCFO | Grant/Award | 84,026 | $29.08 | 84,026(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Jennifer HumesChief Accounting Officer | Grant/Award | 27,157 | $29.08 | 27,157(D) | View → |
| Mar 30, 2026 | Apr 1 11:20 PM | Matthew GlineDirector, CEO | Option Exercise | 2,178,150 | — | 0(D) | View → |
| Mar 30, 2026 | Apr 1 11:19 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 1,306,889 | — | 0(D) | View → |
| Mar 26, 2026 | Mar 31 1:01 AM | Meghan FitzgeraldDirector | Option Exercise | 70,000 | $8.80 | 48,578(D) | View → |
| Mar 17, 2026 | Mar 19 10:36 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,844,834(D) | View → |
| Feb 23, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 587,390 | $3.85 | 3,026,184(D) | View → |
| Feb 20, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,012,610 | $3.85 | 3,613,574(D) | View → |
| Feb 19, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,400,000 | $3.85 | 4,626,184(D) | View → |
| Feb 13, 2026 | Feb 18 10:57 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 5,044,834(D) | View → |
| Feb 9, 2026 | Feb 11 10:53 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 651,558 | $12.68 | 0(D) | View → |